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MembraneSP-BCTERM is a cationic amphipathic helical peptide and functional fragment composed of residues 63 to 78 of
surfactant protein B (SP-B). Static oriented and magic angle spinning solid state NMR, along with molecular
dynamics simulation was used to investigate its structure, orientation, and depth in lipid bilayers of several
compositions, namely POPC, DPPC, DPPC/POPC/POPG, and bovine lung surfactant extract (BLES). In all lipid
environments the peptide was oriented parallel to the membrane surface. While maintaining this approxi-
mately planar orientation, SP-BCTERM exhibited a ﬂexible topology controlled by subtle variations in lipid
composition. SP-BCTERM-induced lipid realignment and/or conformational changes at the level of the head
group were observed using 31P solid-state NMR spectroscopy. Measurements of the depth of SP-BCTERM indi-
cated the peptide center positions ~8 Å more deeply than the phosphate headgroups, a topology that may
allow the peptide to promote functional lipid structures without causing micellization upon compression.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Lung surfactant is a complex mixture of lipids and proteins that is
essential for mammalian breathing. It lowers the surface tension at
the air–water interface in the alveoli, which reduces the work of
breathing and prevents alveolar collapse [1–3]. Absence of sufﬁcient
levels of lung surfactant in premature babies commonly causes respi-
ratory distress syndrome (RDS). Damage to lung surfactant in severe-
ly ill or injured patients is associated with the frequently fatal acute
respiratory distress syndrome (ARDS) [4].ARDS, Acute Respiratory Dis-
dodecyl sulfate; BLES, bovine
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rights reserved.Surfactant protein B (SP-B) is itself an essential component of lung
surfactant, as demonstrated by observations that mice and humans
born without it do not survive [5,6]. SP-B is found in the lung as a di-
sulﬁde linked homodimer [7] and is a member of the saposin super-
family [8] of proteins which conserve a domain fold with 4–5
helices stabilized by 3 intra-chain disulﬁde bonds. SP-B is one of the
most hydrophobic members of this superfamily and its 3D structure
has yet to be experimentally deﬁned. However, micelle-bound struc-
tures have been determined for active fragments of SP-B including
the C-terminal helix, termed SP-BCTERM [9], and a construct composed
of the N and C-terminal helices linked together, termed Mini-B [10].
When compared to native SP-B, Mini-B is slightly more active and
SP-BCTERM retains almost one-half of the activity, as probed by mea-
surements in surfactant deﬁcient rats [11]. Such peptide fragments
of SP-B are interesting subjects of study both in terms of unveiling
the mechanisms of full length SP-B, as well as for their potential in ar-
tiﬁcial lung surfactant therapies for RDS and ARDS.
SP-B and, in some cases its peptide fragments, have been shown to
exhibit a variety of activities in vitro, including promoting lipid ad-
sorption to the air–liquid interface, membrane lysis, membrane fu-
sion, stabilization of monomolecular surface ﬁlms, respreading of
ﬁlms from collapsed phases, and formation of tubular myelin
(reviewed in [7]). While it is not clear which of these activities under-
lie SP-B's essential activity in the lung, it is evident that SP-B has some
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tures. Given their amphipathic helical structure and positive charge,
the N- and C-terminal helices of SP-B resemble many antimicrobial
and cell penetrating peptides. Much about the mechanism of AMPs
and CPPs has been elucidated through biophysical investigations in-
cluding solid state NMR techniques [12–19] and molecular dynamics
simulation [20] to reveal their structures and orientations within lipid
bilayers. However, it should be kept in mind that most SP-B peptides
are substantially more hydrophobic than typical AMPs and that they
act in a very different lipid context, given that the lipid composition
of lung surfactant [21] bears little resemblance to the lipid composi-
tion of lipid bilayers in mammalian or bacterial cell membranes. For
instance, DPPC is generally the most abundant lipid in lung surfactant,
but is not found in cell membranes. To take such differences into con-
sideration, the investigation of SP-B peptides under such distinct ex-
perimental environments is required.
In earlier studies, we determined the high resolution structure of
SP-BCTERM in 40% hexaﬂuoroisopropanol aqueous solution and in mi-
celles composed of sodium dodecyl sulfate (SDS) [9]. Although the
peptide exhibited the same secondary structure in the two solvent
systems, the disposition of the side-chains was quite different, illus-
trating that the functional surface presented by the peptide can be
modiﬁed substantially by its environment. The SDS-bound structure
of SP-BCTERM also displayed a curved hydrophobic surface that
appeared to ﬁt very well into the highly curved surface presented
by the SDS micelle. However, it was not clear whether this observa-
tion indicates a functionally important feature of SP-BCTERM in pro-
moting positive lipid curvature or if this was merely an artifact of
the micelle system in which the structure was determined. Circular
dichroism spectra demonstrate that SP-BCTERM maintains its helical
structure in a variety of environments, including purely zwitterionic
systems such as DPC micelles [22]. Membranes encompassing SP-
BCTERM or a slightly longer version of the C-terminus have also been
investigated using solid state NMR [23,24]. In particular, SP-BCTERM
was investigated in mechanically oriented lipid bilayers using 2H
and 13P solid state NMR to ascertain the peptide's effect on the lipids,
including their head group tilt, chain order and alignment [23]. The
solid state NMR studies with bovine lipid extract surfactant (BLES),
a near complete lung surfactant [25], indicated differences in lipid-
SP-BCTERM's interactions in BLES as compared to model lipid systems
composed of mixtures of POPC and POPG [23]. Thus, in order to un-
derstand the mechanism of SP-BCTERM and its parent protein, the cur-
rent study was undertaken to establish the position and orientation of
SP-BCTERM in lipid bilayers, including those composed of BLES, using
MAS and oriented solid-state NMR techniques.
Solid-state NMR spectroscopy has a proven record for the investi-
gation of membrane-associated polypeptides. Whereas magic angle
spinning of solid or semi-solid samples results in spectra that resem-
ble those obtained in solution and thereby can be used to reveal de-
tailed information such as the position of speciﬁc sites of the
peptide within the bilayer, static oriented samples are used to obtain
angular constraints for structural analysis in the physiologically rele-
vant ﬂuid phase [13–19]. Here, we used these two approaches in
combination with molecular dynamics (MD) simulations to obtain a
more detailed view of the interactions of SP-BCTERM with phospholip-
id bilayers.
2. Materials and methods
2.1. Materials
SP-BCTERM (NH3+-GRMLPQLVCRLVLRCS-COO-) was synthesized via
solid phase methods employing O-ﬂuorenylmethyl-oxycarbonyl
(Fmoc) chemistry, puriﬁed using HPLC, desalted against dilute
5 mM HCl and then distilled H2O and the appropriate amount
weighed out for incorporation into NMR samples as previouslydescribed [9]. For the 15N NMR experiments, 15N was incorporated
at leucine 4, 7, 11, and 13, and valine 8 and 12. For the 13C NMR ex-
periments, three separate peptides were synthesized with a 13C la-
beled backbone carbonyl at either L7, V8, or L11. Bovine lipid
extract surfactant (BLES) was a generous gift from BLES Biochemicals
(London, Canada) and was used after an additional chloroform/meth-
anol extraction based on Bligh and Dyer methods [26], with concen-
tration determined by UV absorption at 815 nm. Lipids were
purchased from Avanti Polar Lipids Inc. (Birmingham, AL) and used
without further puriﬁcation.
2.2. Preparation of oriented samples for static solid state NMR
The BLES sample was prepared using mica plates, as in [23]. For all
other oriented samples, 2 mg of SP-BCTERM and 100 mg lipid were co-
dissolved in a 1:1 chloroform/TFE mixture to homogeneously mix the
peptide and lipid. The resulting solution was concentrated under a
stream of nitrogen, and spread onto 15 ultra-thin microscope cover
glasses (typically 8×22 mm, Marienfeld, Lauda-Königshofen, Germa-
ny). In order to remove all of the organic solvents, the glass plates
were ﬁrst allowed to dry in air and then under high vacuum over-
night. For re-hydration the membrane-covered glass plates were
equilibrated at 93% relative humidity (r.h.) for at least 24 h. Mem-
branes containing DPPC were furthermore incubated in 100% r.h. at
323 K for 2 h, a period which assures good equilibration without un-
necessary exposure of the lipids to elevated temperatures. For NMR
measurements the glass plates supporting the oriented membranes
were stacked on the top of each other and sealed with Teﬂon tape
and plastic ﬁlm [27].
2.3. Preparation of samples for MAS NMR
15 mg of BLES and 0.375 mg of 13C-labeled peptide were dissolved
and mixed in 10 ml of solvent (chloroform/methanol (v/v)=1/1).
Solvent was removed by rotary evaporation at ~46 °C followed by fur-
ther drying under vacuum for overnight. The sample was then dis-
solved in 10 ml of Tris buffer (5 mM TRIS/150 mM NaCl/pH 7.4). For
the samples with Mn2+ present, 15 mM MnCl2 in Tris buffer was
added in the solution, where the molar ratio of BLES/Mn2+ added
was equal to 100/5 assuming a molecular weight of 760 g/mol for
BLES. The solution was kept at 4 °C for 2 h to equilibrate [28] and cen-
trifuged at 50,000 g at 4 °C for 30 min. The pellet was then freeze-
dried for 3 h and rehydrated in a hydration chamber containing satu-
rated ammonia phosphate, for 12 h before being packed into the MAS
rotor.
2.4. Static solid state NMR
For 31P spectra in Fig. 1D only, proton-decoupled 31P solid state
NMR spectra were acquired at 243.02 MHz with a Bruker dual
tuned cross-polarization ﬂat coil probe. A spin echo pulse sequence
(π/2-τ-π-acq) was applied, with a π/2 pulse length of 12 μs, a delay
τ of 22 μs, a recycle delay of 3 s and post acquisition removal of the
FID points before the echo top. The spectral width was 184 ppm,
with SPINAL-64 proton decoupling at strength of 60 kHz [29] and
the temperature set to 20 °C. For 31P spectra shown in Fig. 1A–C,
proton-decoupled 31P spectra were acquired at 161.95 MHz with a
Bruker dual tuned cross-polarization ﬂat coil probe. A spin echo
pulse sequence (π/2-τ-π-acq) was applied, with a π/2 pulse length
of 3.5 μs, a delay τ of 30 μs, and a recycle delay of 3 s. The spectral
width was 476 ppm, with SPINAL-64 proton decoupling at strength
of 40 kHz. The temperatures were set well above the gel state-to-
liquid disordered lipid phase transition (details cf. ﬁgure caption).
All 31P spectra (Fig. 1A–D) were referenced externally to 85% H3PO4
at 0 ppm.
Fig. 2. Proton-decoupled 15N solid-state NMR spectra of SP-B labeled with 15N at amino
acid positions 4, 7, 8, 11, 12 and 13 reconstituted into oriented lipid bilayers composed
of POPC (A–C), DPPC (D), DPPC/POPC/POPG 40/40/20 (E) and BLES (F). The 1H were
decoupled by continuous wave irradiation (B, D–F) or by FSLG homonuclear decou-
pling leaving the heteronuclear 1H–15N dipolar interaction active (C). Panel A shows
a two-dimensional PISEMA spectrum recorded at 4 °C correlating the orientation-
dependent 15N chemical shifts with their corresponding 1H–15N dipolar couplings.
The projection of the chemical shift axis of the PISEMA spectrum (A) is within experi-
mental error identical to the 1D spectrum shown in panel B.
Fig. 1. Proton-decoupled 31P solid-state NMR spectra of glass-plate supported phos-
pholipid membranes in the presence of SP-BCTERM (solid lines) and of the pure mem-
brane (dotted lines). A. POPC, B. DPPC, C. DPPC/POPC/POPG 40/40/20 mole/mole/
mole and D. BLES. The temperature was 25 °C (A), 50 °C (B, C), and 20 °C (D).
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Avance II 14.1 T solid-state NMR spectrometer (Karlsruhe, Germany)
operated at resonance frequency 60.84 MHz for 15N nuclei, refer-
enced with glycine set to 35.7 ppm (corresponding to 0 ppm for liq-
uid NH3). 15N–1H CP experiments were acquired at 20 °C with a
double-resonance ﬂat coil probe, with the bilayer normal parallel to
the external magnetic ﬁeld. The experiments were carried out in a
matched 62.5 kHz B1 ﬁeld with 2 ms of contact time and 5 s of recycle
delay. High power 1H decoupling was applied during signal acquisi-
tion, and the spectrum was collected with 71,680 transients.
All other 15N spectra (i.e. Fig. 2A–E) were performed on a Bruker
Avance DSX500 or a DSX400 spectrometer equipped with standard
ﬂat-coil [30] or commercial e-free ﬂat-coil probes (Bruker, Rheinstet-
ten, Germany). Proton-decoupled 15N experiments were performed
using a cross-polarization (CP) pulse sequence with the followingparameters: 6 μs proton 90° pulse, 800 μs CP contact time using a
shaped pulse at an averaged value of 40 kHz (tangential modulation
on both channels) [31], 2–3 s relaxation delay, about 80,000 scans.
For pure 15N chemical shift spectra a 40 kHz SPINAL64 decoupling
was used. A FSLG decoupling sequence at an effective ﬁeld of
50 kHz reveals both the 15N chemical shift and 1H–15N dipolar cou-
pling [32]. The samples were cooled with a stream of air of ambient
temperature. The resonance of 15NH4Cl as an external reference was
set to 41.5 ppm, corresponding approximately to 0 ppm for liquid
NH3.
The PISEMA experiments [33] were performed with a proton 90°
pulse of 5.97 μs, 6 ms acquisition time, 600 μs CP contact time under
a shaped pulse at an averaged value of 40 kHz (tangential modulation
on both channels) [31]. For each of the 32 t1 experiments 4000 acqui-
sitions were added. The time increment in the ﬁrst dimension was
40 μs and the effective ﬁeld during the SEMA pulse sequence
50 kHz. To increase the sample life time the two-dimensional exper-
iments were performed at 4 °C.
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All MAS spectra were acquired on a Bruker Avance II 14.1 T solid-
state NMR spectrometer (Karlsruhe, Germany). 13C–1H cross polari-
zation (CP) MAS spectra were acquired at −18 °C in a Bruker Triple
tuned CP/MAS probe with spinning rate set at 15 kHz. The experi-
ments were carried out in matched 100 kHz B1 ﬁeld with 2 ms of con-
tact time and 2 s of recycle delay. High power 1H decoupling was
applied during signal acquisition, where each spectrum was collected
with 10,240 transients. The 13C chemical shifts were referenced to
13.9 ppm for the terminal methyl group of lipid acyl chains [34].
2.6. Molecular dynamics simulation
An unrestrained 30 ns MD simulation of SP-BCTERM in a POPC bi-
layer was run using GROMACS [35]. The bilayer originally came
from the website of Mikko Karttunen [36]. The starting structure
used for the peptide was the lowest energy solution NMR structure
of SP-BCTERM in SDS micelles ([9], PDB ID: 1RG4). The peptide was
placed in-plane in an appropriately sized, elliptical hole in the bilayer,
Tip4p water was added, and the appropriate number of water mole-
cules was replaced by sodium counterions to neutralize the charge
of the system. The ﬁnal system had 123 POPC molecules, 1 peptide
and 3821 water molecules. Energy minimization was applied to the
system and then a 10 ps simulation was run with position restraints
on the peptide and lipids. The force ﬁeld employed was based on
OPLS-AA (Optimized Potential for Liquid Systems — All Atoms) [37]
with lipid topology ﬁles from Luca Monticelli and Peter Tieleman
[38]. The production run was a 30 ns unrestrained MD simulations
with temperature maintained at 300 K using Berendsen temperature
coupling and constant box size (i.e. NVT).
3. Results
In order to better understand the effect of lipid composition on SP-
BCTERM/bilayer interactions, proton-decoupled 31P NMR spectra were
acquired in the absence and presence of peptide for mechanically ori-
ented lipid bilayers composed of POPC, DPPC, DPPC/POPC/POPG 40/
40/20 and BLES (Fig. 1). In the absence of peptide the spectra of all
the samples display predominant resonance intensities at ~30 ppm,
i.e. the high-ﬁeld region of the motionally averaged chemical shift
tensors of liquid-disordered PC and PC/PG bilayers, and therefore an
alignment of the lipids with their long axes parallel to the glass
plate normal (dotted lines in Fig. 1A–C). These control experiments
are indicative that the oriented bilayer preparation protocol applied
can result in highly ordered systems (cf. also [39]). However, in the
presence of high amounts of DPPC the alignment is relatively heterog-
enous (Fig. 1B and D), which is probably related to the difﬁculties in
obtaining good alignment for bilayers that tend to be in the gel
phase during most of the equilibration period. For BLES, which con-
tains ~45% DPPC, alignment is also likely affected by other surfactant
components, such as SP-B and SP-C (16). Notably, for all the model
lipid bilayers, but not BLES, the presence of SP-BCTERM increases the
fraction of 31P NMR intensities b20 ppm as well as leads to the ap-
pearance of additional intensities in the 35–40 ppm region. The
changes induced in the model lipid systems by the peptide are indic-
ative of an augmentation of the conformational and/or orientational
heterogeneity at the level of the phospholipid head group.
The effect of the peptide on the apparent 31P chemical shift anisot-
ropy, which reﬂects lipid head group orientation and dynamics, is de-
pendent on the lipid composition (Fig. 1). For POPC the apparent
anisotropy increases by 2–3 ppm, as is evident from the shift of the
maximal intensity to a more downﬁeld position (Fig. 1A). On the
other hand, for DPPC and DPPC/POPC/POPG, the maximal intensity
shifts ~3 ppm upﬁeld, consistent with an anisotropy decrease and/or
an increase in orientational disorder of the membrane (Fig. 1B,C).The changes in 31P peak position in these model lipid systems differ
from the results for BLES, shown here for comparison (Fig. 1D). Previ-
ous work has shown that BLES does not exhibit peptide-induced an-
isotropy changes, in contrast to POPC and/or POPG at the same
temperature [23]. For both DPPC and BLES, a small shoulder appears
on the downﬁeld side of the main peak with addition of peptide.
The orientation of SP-BCTERM in the same oriented bilayer samples
was probed via 15N NMR of partially 15N-labeled peptide (Fig. 2). 15N
was incorporated into the peptide at six positions, ﬁve of which were
in the regular helical part of the peptide as determined in the SDS mi-
celle bound structure [9], and one of which was just N-terminal to the
deﬁned part of the helix. Fig. 2B shows that for SP-BCTERM in POPC,
there are unresolved spectral intensities ranging from 65 to
105 ppm which are centered around 85–90 ppm. This chemical shift
range indicates that the NH vectors are oriented perpendicular to
the magnetic ﬁeld direction (Bo). Since for these samples the bilayer
normal is aligned parallel to Bo, this is consistent with an alignment
of the predominantly helical peptide parallel to the membrane sur-
face [40]. Fig. 2A shows a two-dimensional separated local ﬁeld spec-
trum where the 15N chemical shift is correlated with the 15N–1H
dipolar coupling of about 11 kHz. Furthermore, by recording a one-
dimensional 15N solid-state NMR spectrum where the homonuclear
1H interactions only are removed and the heteronuclear 1H–15N dipo-
lar couplings remain [32], an average value for the latter of 10.5 kHz is
observed (Fig. 2C). These dipolar coupling measurements conﬁrm the
in-planar alignment of the peptide [13,41].
When the SP-BCTERM is reconstituted in oriented membranes of
different compositions, the predominant in-planar signal intensity re-
mains. However, in oriented DPPC membranes at 323 K small addi-
tional contributions appears around 120–130 ppm suggesting that
some of the peptides and/or sites adopt a more tilted alignment rela-
tive to the sample normal and/or undergo motional averaging
(Fig. 2D). In the presence of DPPC/POPC/POPG 40/40/20 (mole/
mole/mole) a small fraction of the signal intensity appears in the
160–210 ppm region suggesting that part of the peptides are oriented
approximately parallel to the glass plate normal (Fig. 2E). Although
the peptide is labeled at six different sites, neither the one- nor the
two-dimensional solid-state NMR spectra resolve the different reso-
nances regardless of the lipid composition of the membranes, indicat-
ing that the peptide displays some structural and/or orientational
heterogeneity. In addition to the model lipid systems, a spectrum
was also acquired in BLES (Fig. 2F). In BLES, the main 15N peak is
shifted slightly upﬁeld, suggesting a somewhat more parallel orienta-
tion of the peptide in real lung surfactant, compared to the model
lipid systems.
In order to measure the depth of insertion of SP-BCTERM in vesicles
composed of BLES, we used 13C MAS spectra, in the absence and pres-
ence of the paramagnetic probe Mn2+. Firstly, 13C MAS spectra were
acquired for BLES in the absence of peptide and Mn2+ (Fig. 3A). Al-
though BLES is a complex mixture of proteins and lipids, including
DPPC, POPC, and POPG, most 13C peaks could be assigned based on
published spectra of saturated and unsaturated phospholipids (e.g.
[28,42]). As expected, the inclusion of 15 mM Mn2+ abrogated all
peaks originating from the lipid head group region (Fig. 3B).
Next 13C MAS spectra were acquired for three different BLES sam-
ples with SP-BCTERM (Fig. 4). One sample contained SP-BCTERM with a
13C isotope label on the carbonyl of L7, one with the label on V8 and
one with the label on L11. In the absence of Mn2+, the 13C spectra
look similar for the three peptides, and except for the carbonyl region
(~173 ppm) look similar to the spectrum in the absence of peptide
(Fig. 3A). A corresponding set of spectra was acquired with the addi-
tion of Mn2+ to the samples (Fig. 4). The loss of lipid peak intensity
with Mn2+ was used to make a calibration curve (Fig. 5) using the av-
eraged intensity for the lipid regions from the three separate sets of
samples. The loss of peak intensity of the carbonyl region, which con-
tains the signal from the peptide, was then plotted on this curve for
Fig. 3. 13C MAS spectra of BLES in the absence (A) and presence (B) of 15 mM Mn2+.
Fig. 4. 13C MAS spectra of BLES with various 13C-labeled SP-BCTERM peptides. (A) SP-
BCTERM L7 13C-carbonyl, (B) SP-BCTERM V8 13C-carbonyl, (C) SP-BCTERM L11 13C-carbonyl.
In each pair, the upper spectrum corresponds to the Mn2+-free samples and the lower
to the sample with Mn2+.
Fig. 5. Loss of intensity of 13C peaks with the addition of Mn2+. The intensities are nor-
malized to that of the CH3 (ω) peak and the ratio of this normalized intensity without
and with Mn2+ plotted on the y-axis. For each lipid region, the average value from the
3 spectra in Fig. 4 is plotted. The values for the 13C-carbonyl labeled peptides are shown
as horizontal lines.
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sition indicated by the three peptides, which is probably due to low
signal-to-noise, rather than detectable differences in the positions of
these atoms within the bilayers. Taken together, the data indicate
the peptide backbone positions slightly more toward the polar inter-
face than the double bonds in the lipid acyl chains.
Molecular dynamics simulations of SP-BCTERM in a POPC bilayer
were run to provide atomistic insight into the interactions that
might be stabilizing the observed tilt and depth of the peptide
(Fig. 6). These were run starting with the NMR structure of SP-
BCTERM [9] inserted into an appropriately sized premade hole in the
bilayer and were performed without any restraints to maintain the
original structure of the peptide. Shortly after the start of the 30 ns
simulation, the acyl chains from the leaﬂet without the peptide ﬁll
in the void under the peptide. While the observed thinning of the bi-
layer in the vicinity of the peptide may arise from the hole that was
made to accommodate the peptide in the initial set-up, it is also con-
sistent with the bilayer thinning commonly produced by amphipath-
ic, cationic peptides that are less hydrophobic than SP-BCTERM
[43–45]. Over the ﬁrst 15 ns of the simulation the peptide rises from
its initial position to a position slightly closer to the polar/apolar in-
terface, and maintains this position for the remainder of the simula-
tion. The positions of the carbonyl atoms that were probed in the
Mn2+ experiments are shown as spheres in Fig. 6A–C and consistent
with the experimental data, these locate to just above the C_C bonds
in the lipid acyl chains. Peptide depth was more precisely quantiﬁed
using a density proﬁle (Fig. 6D) which indicates that the 13C labeled
atoms localize 10.9 Å nm deeper than the phosphorous atoms in the
lipid head groups, and the entire peptide localizes an average of
8.3 Å deeper than the lipid phosphorous atoms. Also consistent with
the 15N spectra, the peptide is in a largely planar position, with only
a slight tilt; the average angle between the HN bond vector (from
the 15N labeled residues 7, 8, 10, 11 and 13) and the bilayer normal
is 80°.
4. Discussion
The 15N spectra of SP-BCTERM (Fig. 2) indicate a primarily surface
orientation of the peptide in all the environments examined, i.e.
POPC, DPPC, DPPC/POPC/POPG 40/40/20 and BLES. This orientation
is in good agreement with the non-transmembrane orientation of
SP-BCTERM indicated by transcription–translation assays [46], the
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phipathic character of the mostly hydrophobic peptide carrying at
the same time 3 positively charged arginines. The lack of resolutionand limited signal-to-noise ratio of the spectra relate to the intrinsic
structural and/or topological heterogeneity of this peptide. Although
the observed heterogeneity makes structural analysis of bilayer-
bound SP-BCTERM in atomic detail difﬁcult, all the collected data
(chemical shift and dipolar) are indicative of a similar predominant
orientation of the N–H vectors. While very slight kinks in SP-BCTERM
cannot be eliminated by the data, any substantial kink or curvature
in the peptide would result in 15N signals >105 ppm. These are not
observed in either the 1D or PISEMA spectra, thus indicating that
such conformations are absent, or occur in only a very small fraction
of the population. Thus, as suspected, the curvature observed in the
structures determined by solution NMR [9] is likely an artifact of the
SDS micelles employed in the structure determination.
The width of SP-BCTERM's 15N peak is substantially broader than
has been observed for other amphipathic peptides such as magainin
2 [47], magainin derivatives (e.g. [48]), piscidin [49], pleurocidin
[50] or designed peptides [51,52], which give much sharper 15N
peaks. The broadness of SP-BCTERM's 15N peak resembles more what
is observed for peptides such as peptaboils [53,54], or PGLa [47].
That SP-BCTERM, PGLa, and peptaboils are all considerably more apolar
than magainin and many other antimicrobial peptides, suggests that
the observed instability is related to the greater hydrophobicity of
these peptides. Furthermore, broadened line shapes of both the 15N
and the 31P chemical shift solid-state NMR spectra have been ob-
served for other arginine-rich peptides [47,55], suggesting that the
hydrogen bonding capacity of these residues introduces additional
conformational and topological heterogeneity on the time scale of
these solid-state NMR experiments. While SP-BCTERM resembles
PGLa and peptaboils in terms of 15N linewidth, unlike these peptides
[56], no predominant transmembrane orientations were observed for
SP-BCTERM in any of the lipid systems, suggesting that in the lung sur-
factant environment the heterogeneity observed is limited to near-
planar orientations with, at most, only a small fraction occurring at
transmembrane tilt angles.
Although SP-BCTERM remained largely planar with respect to the
bilayer surface in all lipid compositions examined, it appeared to
take on a slightly more parallel angle in BLES as compared to its posi-
tion in the model lipid systems. BLES retains a similar composition to
native lung surfactant, except that the hydrophilic lung surfactant
proteins SP-A and SP-D and at least some of the cholesterol have
been removed [25]. Since BLES contains ~45% DPPC, ~40% unsaturated
PC, and ~15% anionic lipid, its phospholipid components are reason-
ably well mimicked by the 40/40/20 DPPC/POPC/POPG mixture used
in this study. Thus, the apparent differences in peptide tilt angle
may arise from the presence in BLES of the hydrophobic lung surfac-
tant proteins SP-B and SP-C and/or from subtle differences in lipid
composition.
Membrane disordering of oriented membranes is a recurring ob-
servation with in-plane oriented amphipathic arginine- [47,55] and
lysine-rich peptides (e.g. [57,58]), which, including SP-B C-terminal
peptides, have also been observed to selectively interact with anionic
lipids in mixed membranes [23,24,59]. The subtle changes in the
motionally averaged 31P CSA observed here as a function of lipid com-
position are therefore probably related to differences in membrane
penetration depth of the peptide, which is concomitant with anFig. 6. Snapshots from the molecular dynamics simulation of SP-BCTERM in a POPC bilay-
er at 0 ns (A) and 30 ns (B, C). The view is rotated by 90° between (B) and (C). The pep-
tide backbone is shown as a yellow ribbon and the sidechains are colored with
hydrophobic, white, positively charged, blue, and polar, green. The carbonyls on L7,
V8 and L11 (that were 13C-labeled in the MAS experiments) are shown as spheres col-
ored cyan, blue, and green, respectively. The C_C bonds on the POPC acyl chains are
drawn as rods. (D) Number density along the normal to the bilayer averaged over
the last 10 ns of the simulation. Protein atoms are in black, L7, V8, and L11 backbone
atoms are in red, lipid phosphorous atoms in green, and lipid CH atoms in blue (so
that the inner CH peaks correspond to the position of the acyl chain double bonds).
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ing sites from the arginine residues [61]. Differences in lung surfac-
tant peptide–lipid interactions have been seen when membranes
made of saturated and unsaturated phospholipids are compared to
each other [24,62]. Furthermore, the membrane structure and the as-
sociated 31P NMR spectra are affected by modiﬁcations in electric sur-
face charge density [60]. Finally peptides intercalated into the
membrane interface have been shown to alter the membrane thick-
ness as well as the dynamics and undulations of the bilayer, structural
changes that have been shown to be reﬂected in the 31P CSA [58].
Bilayer depth was probed for SP-BCTERM in BLES using paramag-
netic probes (Figs. 4 and 5). The results indicate that SP-BCTERM posi-
tions with the backbone residues of its hydrophobic face slightly
more shallowly than the double bonds in the acyl chain of POPC. As
can be seen in the molecular dynamics snapshots and proﬁle in
Fig. 6, this puts the peptide as a whole in a position where it does
not reach the center of the bilayer, but has extensive interactions
with both the acyl chain and head group regions at the interface.
This positioning is consistent with what has previously been observed
in the 2H order parameter proﬁles of SP-BCTERM in unsaturated bila-
yers. SP-BCTERM markedly decreased the order of the acyl chains in
oriented POPC and POPC/POPG bilayers [23]. A slightly longer version
of SP-BCTERM showed similar results in multilamellar vesicles com-
posed of POPC/POPG [24]. I.e. in these lipid systems, SP-BCTERM posi-
tions at the interface and thus induces disorder in the acyl chain
regions deep in the bilayer. This is in contrast to what is observed
for antimicrobial peptides like almethicin [44], which penetrate so
deeply in the bilayer, they restrain the motions of the acyl chains so
that there is little effect on the order parameter proﬁle.
Extensive molecular dynamics studies of SP-B have been per-
formed by other workers (e.g. [63,64]) and so here, the focus of the
simulations was to provide some insight into the speciﬁc peptide/
lipid interactions that can stabilize SP-BCTERM's position within the bi-
layer (Fig. 6). The simulations indicate a peptide depth and tilt angle
consistent with the NMR data. In this position, the 5 polar/charged
residues of SP-BCTERM can extend up to make contact with the lipid
polar head group/water region. However, given the structure of the
peptide and the distribution of the hydrophobic residues within the
sequence, some of the hydrophobic sidechains extend into this region
as well. It is possible that this positioning of the hydrophobic side-
chains helps draw lipids out of the bilayer as has been suggested for
granulysin [65] and promotes the lipid structures necessary for lung
surfactant function.
Given SP-BCTERM's alignment parallel to the membrane surface and
its position slightly above the center of each leaﬂet in the bilayer, this
peptide is likely to induce a modest, positive curvature strain on the
bilayer [66]. Such an “intermediate” depth and curvature strain
could be key in the function of this peptide and its parent protein,
SP-B. For example, it might allow SP-B to promote lipid structures
that are favored by positive curvature strain, such as the buckled
structures observed during compression of anionic bilayers contain-
ing SP-B [67] or distortions that lower the energy barrier to lipid in-
sertion into the surface monolayer [68]. However, importantly, the
protein may not induce sufﬁcient curvature strain so as to cause
micellization at high surface pressures.
Overall, the observations made are consistent with ﬁne-tuning of
structure–function relationships in SP-BCTERM, and its parent protein
SP-B, to allow them to take on multifunctional roles within lung sur-
factant. The apparent modulation of the peptide's tilt angle and effect
on lipid head group orientation by subtle changes in bilayer composi-
tion is a case in point. The depth of the peptide measured in BLES and
predicted in the molecular dynamics simulations in POPC suggests
that its effects on curvature strain are likely to be modest, in congru-
ence with its ability to promote functionally important lipid struc-
tures, without causing the lipid layers to micellize at high surface
pressures.Acknowledgements
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